CNO Financial Group, Inc.
$53.96-$1.06 (-1.9%)
Last close · Data as of Nov 20, 2026
- Market cap
- $4.4B
- P/E
- 19.2x
- Revenue
- $4.5B
- Net margin
- 5.1%
- ROCE
- 7.8%
Price chart
Technical chartScreen technicals →+35.7% over the last year
Daily closes.
Go deeper
Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes
Performance
Price return, before dividends, to the 20 Nov 2026 close.
- 1M
- -1.6%
- 3M
- +1.6%
- 6M
- +14.2%
- 1Y
- +35.7%
- 5Y
- +125.4%
52-week range
Day change -$1.06 (-1.9%) from $55 to $54 · Last close Nov 20, 2026
Best weekday to invest, historically
The same weekly amount in CNO, bought on each weekday since 2021.
News & filings
What CNO Financial Group filed, who traded, and what's next
How to read this
"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.
AI Summary
US StockStrengthFree cash flow in fiscal 2025 equals 15.4% of the company's market value.
Concerns (1)
- Return on equity of 8.7% against a peer median of 11.5%.
Prices to the 20 Nov 2026 close · Financial year: fiscal 2025
Rule-based from financial data. Not advice.
About the company
CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance and other insurance products, and financial services for middle-income pre-retiree and retired Americans in the United States.
Read moreShow less
CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance and other insurance products, and financial services for middle-income pre-retiree and retired Americans in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individual consumers through phone, virtually, online, and face-to-face with agents. The company also focuses on sale of voluntary benefit life and health insurance products for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed indexed annuities; fixed interest annuities, including fixed rate single-premium deferred annuities; flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees, lesser degree, and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. It markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company was founded in 1979 and is headquartered in Carmel, Indiana.
- Sector
- Financial Services
- Shares outstanding
- 97.6M
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- $4.4B
- P/E
- 19.2x
- P/B
- 1.7x
- EV / Sales
- 1.7x
- P/S
- 1.0x
- 52-week high
- $58.49
- 52-week low
- $39.55
Profitability
- Operating margin
- 11.7%
- Net margin
- 5.1%
- ROE
- 8.7%
- ROCE
- 7.8%
- ROIC
- 7.1%
- ROA
- 0.6%
- Asset turnover
- 0.12
Growth
- RevenueFY2025, the latest fiscal year in the company's growth history.
- $4.5B
- Revenue growth, 1YFY2025, the latest fiscal year in the company's growth history.
- 0.9%
- Revenue CAGR, 3YFY2025, the latest fiscal year in the company's growth history.
- 7.9%
- Net profit growth, 1YFY2025, the latest fiscal year in the company's growth history.
- -45.5%
- Free cash flowFY2025, the latest fiscal year in the company's growth history.
- $675.7M
Solvency
- Debt / Equity
- 1.54
- Debt / Assets
- 0.10
- CFO / Net profit
- 2.95
- Cash / Market cap
- 21.7%
Where the revenue went
Some FY2025 lines are not reported, so the ones that are appear as a table.
| Line | FY2025 |
|---|---|
| Revenue | $4.5B |
| Gross profit | $4.5B |
| Operating expenses | — |
| Selling, general and administrative | $305.0M |
| Pretax income | $293.4M |
| Tax and other | $64.1M |
| Net income | $229.3M |
Revenue and net profit
Revenue grew 0.9% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2022 | $3.6B | $630.6M |
| FY2023 | $4.1B | $276.5M |
| FY2024 | $4.4B | $420.8M |
| FY2025 | $4.5B | $229.3M |
Cash flows
FY2025: $675.7M from operations, $675.7M free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2022 | $495.4M | $495.4M |
| FY2023 | $582.9M | $582.9M |
| FY2024 | $627.7M | $627.7M |
| FY2025 | $675.7M | $675.7M |
Growth
Latest fiscal year 2025: each figure with its change over the year before.
- Revenue
- $4.5B+0.9%1Y
- Net profit
- $229.3M-45.5%1Y
- Cash from operations
- $675.7M+7.6%1Y
- Free cash flow
- $675.7M+7.6%1Y
- Revenue CAGR, 3Y
- 7.9%
- Net profit CAGR, 3Y
- -28.6%
| Year | Revenue | EBITDA | Net profit | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|
| FY2025 | $4.5B | — | $229.3M | $675.7M | 8.7% | +0.9% | -45.5% |
Monthly returns
Month-by-month returns of CNO across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Assets | $38.8B |
| Current assets | — |
| Non-current assets | — |
| Liabilities | $36.2B |
| Non-current liabilities | — |
| Equity | $2.6B |
| Paid-in capital | $1.3B |
| Retained earnings | $2.4B |
Market cap against peers
8 peers: same sector, nearest by size.
Peers map
Financial Services companies placed by value, growth and quality; CNO highlighted.
P/E against peers
CNO trades at 19.2x earnings against a peer median of 12.8x (a 50% premium).
Not shown (no positive earnings and no EV / Sales): Lemonade, Inc.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| CNO Financial Group, Inc.CNOthis companyP/E ↑ premium | $4.4B | 19.2x | 1.7x | 8.7% | — |
| Nelnet, Inc.NNI | $4.7B | 11.1x | 1.3x | 11.4% | — |
| First Financial Bankshares, Inc.FFIN | $4.6B | 18.3x | 2.4x | 13.2% | — |
| International Bancshares CorporationIBOC | $4.5B | 11.0x | 1.4x | 12.7% | — |
| Texas Capital Bancshares, Inc.TCBI | $4.5B | 13.5x | 1.3x | 9.9% | — |
| Eastern Bankshares, Inc.EBC | $4.3B | 49.0x | 1.0x | 2.0% | — |
| PennyMac Financial Services, Inc.PFSI | $4.2B | 8.4x | 1.0x | 11.6% | 43.5x |
| Lemonade, Inc.LMND | $4.0B | — | 7.4x | -31.0% | — |
| Marex Group plcMRX | $3.9B | 12.8x | 3.1x | 24.3% | 9.3x |
| Peer median | — | 12.8x | 1.4x | 11.5% | 26.4x |
Year-to-date ROI
CNO since 1 January, against earlier years.
Historical volatility
CNO's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.
Consolidated figures in USD, fiscal years, newest first.
| Line | FY2025 |
|---|---|
| RevenueTotal Revenue | $4.5B |
| Operating expenses | |
| Selling, general and administrativeSelling General And Administration | $305.0M |
| Other operating expensesOther Operating Expenses | $680.0M |
| Depreciation and amortisationDepreciation And Amortization In Income Statement | — |
| Amortization | — |
| Total expensesTotal Expenses | $4.2B |
| Interest and other | |
| Pretax incomePretax Income | $293.4M |
| TaxTax Provision | $64.1M |
| Net incomeNet Income | $229.3M |
| Per share | |
| Supplementary | |
| Other lines |
| Line | FY2025 |
|---|---|
| AssetsTotal Assets | $38.8B |
| Current assets | |
| Non-current assets | |
| LiabilitiesTotal Liabilities Net Minority Interest | $36.2B |
| Current liabilities | |
| Non-current liabilities | |
| EquityTotal Equity Gross Minority Interest | $2.6B |
| Supplementary |
| Line | FY2025 |
|---|---|
| Operating cash flowOperating Cash Flow | $675.7M |
| Cash from continuing operationsCash Flow From Continuing Operating Activities | $675.7M |
| Net income, continuing operationsNet Income From Continuing Operations | $229.3M |
| Depreciation and amortisationDepreciation And Amortization | $318.5M |
| Amortization of securitiesAmortization Of Securities | -$499.3M |
| Deferred taxDeferred Tax | $26.3M |
| Deferred income taxDeferred Income Tax | $26.3M |
| Operating gains and lossesOperating Gains Losses | $54.7M |
| Gain loss on investment securitiesGain Loss On Investment Securities | $54.7M |
| Asset impairmentAsset Impairment Charge | $101.9M |
| Change in working capitalChange In Working Capital | $618.1M |
| Other non-cash itemsOther Non Cash Items | -$173.8M |
| Investing cash flowInvesting Cash Flow | -$1.7B |
| Cash from continuing investingCash Flow From Continuing Investing Activities | -$1.7B |
| Purchase of investmentsPurchase Of Investment | -$8.5B |
| Sale of investmentsSale Of Investment | $6.8B |
| Net investment purchases and salesNet Investment Purchase And Sale | -$1.7B |
| Other investing changesNet Other Investing Changes | -$3.2M |
| Financing cash flowFinancing Cash Flow | -$22.6M |
| Cash from continuing financingCash Flow From Continuing Financing Activities | -$22.6M |
| Debt issuedIssuance Of Debt | $776.8M |
| Debt repaidRepayment Of Debt | -$1.3B |
| Net debt issuedNet Issuance Payments Of Debt | -$485.0M |
| Long-term debt issuedLong Term Debt Issuance | $776.8M |
| Long-term debt repaidLong Term Debt Payments | -$1.3B |
| Net long-term debt issuedNet Long Term Debt Issuance | -$485.0M |
| Shares issuedIssuance Of Capital Stock | $11.6M |
| Common stock issuedCommon Stock Issuance | $11.6M |
| Net common stock issuedNet Common Stock Issuance | -$319.8M |
| Common stock repurchasedCommon Stock Payments | -$331.4M |
| Share buybacksRepurchase Of Capital Stock | -$331.4M |
| Dividends paidCash Dividends Paid | -$66.2M |
| Common dividends paidCommon Stock Dividend Paid | -$66.2M |
| Other financing chargesNet Other Financing Charges | $848.4M |
| Change in cashChanges In Cash | -$1.0B |
| Cash at the start of the yearBeginning Cash Position | $2.0B |
| Cash at the end of the yearEnd Cash Position | $983.5M |
| Free cash flowFree Cash Flow | $675.7M |
Learn while you research
Academy chapters picked for CNO Financial Group, Inc. and the metrics on this page.
- 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 02 Leverage RatiosDebt/Equity of 1.54 is elevated, understand what that means for solvency.6 min read
- 03 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 04 Sector AnalysisBanks & financials are uniquely sensitive to rates and credit cycles.6 min read
- 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read